Total, unbound plasma and salivary phenytoin levels in critically ill patients

Detalhes bibliográficos
Autor(a) principal: Ibarra,M.
Data de Publicação: 2010
Outros Autores: Vázquez,Marta, Fagiolino,P., Mutilva,F., Canale,A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of epilepsy and clinical neurophysiology (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492010000200006
Resumo: OBJECTIVE: To assess the reliability of salivary phenytoin (PHT) concentrations and predicted free PHT levels by Sheiner-Tozer equation in order to substitute measured free PHT concentrations in critically ill patients. METHODOLOGY: Twenty-four neurocritically ill adult patients receiving intravenous PHT were included in the study. Analyses of total, free plasma and saliva PHT concentrations were performed by fluorescence polarization immunoassay. Plasma albumin levels were also determined. RESULTS: Free PHT concentrations as well as salivary levels better correlate to clinical effect than total drug concentrations. Linear regression analysis showed a strong correlation between estimated free PHT concentrations by Sheiner-Tozer and measured free PHT levels (r=0.835; p<0.001) and salivary PHT concentrations and measured free PHT concentrations (r=0.964; p<0.001). Sheiner-Tozer equation could be misleading in the presence of displacing drugs. CONCLUSIONS: Saliva may serve as a feasible fluid to plasma in order to be used as a surrogate for free concentration monitoring of PHT in this population.
id LBE-1_a301fb7f6a35aa55bbf93172f299eea4
oai_identifier_str oai:scielo:S1676-26492010000200006
network_acronym_str LBE-1
network_name_str Journal of epilepsy and clinical neurophysiology (Online)
repository_id_str
spelling Total, unbound plasma and salivary phenytoin levels in critically ill patientsPhenytoinunbound concentrationsaliva concentrationSheiner-Tozer equationOBJECTIVE: To assess the reliability of salivary phenytoin (PHT) concentrations and predicted free PHT levels by Sheiner-Tozer equation in order to substitute measured free PHT concentrations in critically ill patients. METHODOLOGY: Twenty-four neurocritically ill adult patients receiving intravenous PHT were included in the study. Analyses of total, free plasma and saliva PHT concentrations were performed by fluorescence polarization immunoassay. Plasma albumin levels were also determined. RESULTS: Free PHT concentrations as well as salivary levels better correlate to clinical effect than total drug concentrations. Linear regression analysis showed a strong correlation between estimated free PHT concentrations by Sheiner-Tozer and measured free PHT levels (r=0.835; p<0.001) and salivary PHT concentrations and measured free PHT concentrations (r=0.964; p<0.001). Sheiner-Tozer equation could be misleading in the presence of displacing drugs. CONCLUSIONS: Saliva may serve as a feasible fluid to plasma in order to be used as a surrogate for free concentration monitoring of PHT in this population.Liga Brasileira de Epilepsia (LBE)2010-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492010000200006Journal of Epilepsy and Clinical Neurophysiology v.16 n.2 2010reponame:Journal of epilepsy and clinical neurophysiology (Online)instname:Liga Brasileira de Epilepsia (LBE)instacron:LBE10.1590/S1676-26492010000200006info:eu-repo/semantics/openAccessIbarra,M.Vázquez,MartaFagiolino,P.Mutilva,F.Canale,A.eng2010-09-16T00:00:00Zoai:scielo:S1676-26492010000200006Revistahttp://epilepsia.org.br/publicacoes/ONGhttps://old.scielo.br/oai/scielo-oai.php||jecnpoa@terra.com.br1980-53651676-2649opendoar:2010-09-16T00:00Journal of epilepsy and clinical neurophysiology (Online) - Liga Brasileira de Epilepsia (LBE)false
dc.title.none.fl_str_mv Total, unbound plasma and salivary phenytoin levels in critically ill patients
title Total, unbound plasma and salivary phenytoin levels in critically ill patients
spellingShingle Total, unbound plasma and salivary phenytoin levels in critically ill patients
Ibarra,M.
Phenytoin
unbound concentration
saliva concentration
Sheiner-Tozer equation
title_short Total, unbound plasma and salivary phenytoin levels in critically ill patients
title_full Total, unbound plasma and salivary phenytoin levels in critically ill patients
title_fullStr Total, unbound plasma and salivary phenytoin levels in critically ill patients
title_full_unstemmed Total, unbound plasma and salivary phenytoin levels in critically ill patients
title_sort Total, unbound plasma and salivary phenytoin levels in critically ill patients
author Ibarra,M.
author_facet Ibarra,M.
Vázquez,Marta
Fagiolino,P.
Mutilva,F.
Canale,A.
author_role author
author2 Vázquez,Marta
Fagiolino,P.
Mutilva,F.
Canale,A.
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Ibarra,M.
Vázquez,Marta
Fagiolino,P.
Mutilva,F.
Canale,A.
dc.subject.por.fl_str_mv Phenytoin
unbound concentration
saliva concentration
Sheiner-Tozer equation
topic Phenytoin
unbound concentration
saliva concentration
Sheiner-Tozer equation
description OBJECTIVE: To assess the reliability of salivary phenytoin (PHT) concentrations and predicted free PHT levels by Sheiner-Tozer equation in order to substitute measured free PHT concentrations in critically ill patients. METHODOLOGY: Twenty-four neurocritically ill adult patients receiving intravenous PHT were included in the study. Analyses of total, free plasma and saliva PHT concentrations were performed by fluorescence polarization immunoassay. Plasma albumin levels were also determined. RESULTS: Free PHT concentrations as well as salivary levels better correlate to clinical effect than total drug concentrations. Linear regression analysis showed a strong correlation between estimated free PHT concentrations by Sheiner-Tozer and measured free PHT levels (r=0.835; p<0.001) and salivary PHT concentrations and measured free PHT concentrations (r=0.964; p<0.001). Sheiner-Tozer equation could be misleading in the presence of displacing drugs. CONCLUSIONS: Saliva may serve as a feasible fluid to plasma in order to be used as a surrogate for free concentration monitoring of PHT in this population.
publishDate 2010
dc.date.none.fl_str_mv 2010-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492010000200006
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492010000200006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1676-26492010000200006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Liga Brasileira de Epilepsia (LBE)
publisher.none.fl_str_mv Liga Brasileira de Epilepsia (LBE)
dc.source.none.fl_str_mv Journal of Epilepsy and Clinical Neurophysiology v.16 n.2 2010
reponame:Journal of epilepsy and clinical neurophysiology (Online)
instname:Liga Brasileira de Epilepsia (LBE)
instacron:LBE
instname_str Liga Brasileira de Epilepsia (LBE)
instacron_str LBE
institution LBE
reponame_str Journal of epilepsy and clinical neurophysiology (Online)
collection Journal of epilepsy and clinical neurophysiology (Online)
repository.name.fl_str_mv Journal of epilepsy and clinical neurophysiology (Online) - Liga Brasileira de Epilepsia (LBE)
repository.mail.fl_str_mv ||jecnpoa@terra.com.br
_version_ 1754734659598548992